Search Results - "Staretz‐Chacham, O."
-
1
Mitochondrial epileptic encephalopathy, 3‐methylglutaconic aciduria and variable complex V deficiency associated with TIMM50 mutations
Published in Clinical genetics (01-05-2017)“…Mitochondrial encephalopathies are a heterogeneous group of disorders that, usually carry grave prognosis. Recently a homozygous mutation, Gly372Ser, in the…”
Get full text
Journal Article -
2
Incidence of inherited metabolic disorders in southern Israel: a comparison between consanguinity and non-consanguinity communities
Published in Orphanet journal of rare diseases (25-11-2020)“…Inherited metabolic disorders (IMDs) are group of rare monogenic diseases, usually derived from reduced or absent activity in a single metabolic pathway. Most…”
Get full text
Journal Article -
3
Familial factor VII deficiency with foetal and neonatal fatal cerebral haemorrhage associated with homozygosis to Gly180Arg mutation
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01-05-2009)“…Inherited factor VII (FVII) deficiency is a rare autosomal recessive disorder with a wide heterogeneous clinical pattern. Intracranial haemorrhage in infants…”
Get full text
Journal Article -
4
Glyceryl triacetate for Canavan disease: A low-dose trial in infants and evaluation of a higher dose for toxicity in the tremor rat model
Published in Journal of inherited metabolic disease (01-10-2009)“…Canavan disease (CD) is a fatal dysmyelinating genetic disorder associated with aspartoacylase deficiency, resulting in decreased brain acetate levels and…”
Get full text
Journal Article -
5
Update on safety and efficacy results for phase I/II trial of hydroxypropyl betacyclodextrin (HPâCD) administered intravenously in patients with Niemann-Pick disease type C1
Published in MOLECULAR GENETICS AND METABOLISM (01-02-2021)Get full text
Journal Article Conference Proceeding -
6
Long-term administration of intravenous Trappsol® Cyclo™ (HP-β-CD) results in clinical benefits and stabilization or slowing of disease progression in patients with Niemann-Pick disease type C1: Results of an international 48-week Phase I/II trial
Published in Molecular genetics and metabolism reports (01-09-2023)“…Niemann-Pick disease type C (NPC) is a rare, fatal, pan-ethnic, autosomal recessive lysosomal storage disease characterized by progressive major organ failure…”
Get full text
Journal Article -
7
Glyceryl triacetate for Canavan disease: A low-dose trial in infants and evaluation of a higher dose for toxicity in the tremor rat model: Neurological manifestations of IEM in children, dedicated to Robert Surtees
Published in Journal of inherited metabolic disease (2009)Get full text
Journal Article